BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11352860)

  • 21. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
    Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
    Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
    Bradbury BD; Lash TL; Kaye JA; Jick SS
    Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
    Kaufman EL; Jacobson JS; Hershman DL; Desai M; Neugut AI
    J Clin Oncol; 2008 Jan; 26(3):392-8. PubMed ID: 18202415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cigarette smoking and risk of breast carcinoma in situ.
    Trentham-Dietz A; Nichols HB; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
    Epidemiology; 2007 Sep; 18(5):629-38. PubMed ID: 17700252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
    de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
    J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
    Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
    ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer.
    Sarp S; Fioretta G; Verkooijen HM; Vlastos G; Rapiti E; Schubert H; Sappino AP; Bouchardy C
    Ann Surg Oncol; 2007 Mar; 14(3):1031-9. PubMed ID: 17176985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
    Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC
    Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors.
    Ford MB; Sigurdson AJ; Petrulis ES; Ng CS; Kemp B; Cooksley C; McNeese M; Selwyn BJ; Spitz MR; Bondy ML
    Cancer; 2003 Oct; 98(7):1457-64. PubMed ID: 14508833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
    Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
    Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
    Shen J; Hunt KK; Mirza NQ; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Ross MI; Ames FC; Feig BW; Singletary SE; Cristofanilli M; Meric-Bernstam F
    Cancer; 2005 Aug; 104(3):479-90. PubMed ID: 15968686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
    Hemminki K; Granström C
    Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
    Fisher ER; Land SR; Saad RS; Fisher B; Wickerham DL; Wang M; Costantino JP; Wolmark N
    Am J Clin Pathol; 2007 Jul; 128(1):86-91. PubMed ID: 17580274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.